HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy
We report the case of a 45-year-old patient diagnosed, after four years from the initial diagnosis of infiltrating ductal carcinoma, with lymph node, hepatic, pulmonary and bone diseases deriving from HER2-positive breast cancer. While the association docetaxel + trastuzumab led to a partial respon...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2018-06-01
|
Series: | AboutOpen |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/160 |